We are live on ! Find out more
MC

Marcus Capital Portfolio holdings

AUM $34.3M
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+30.44%
3 Year Est. Return
+101.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$104M
AUM Growth
+$9.08M
Cap. Flow
-$318K
Cap. Flow %
-0.31%
Top 10 Hldgs %
36.42%
Holding
52
New
1
Increased
27
Reduced
16
Closed
1

Top Buys

1
COST icon
Costco
COST
+$824K
2
P
Everpure Inc
P
+$747K
3
ACHN
Achillion Pharmaceuticals
ACHN
+$638K
4
DATA
Tableau Software, Inc.
DATA
+$568K
5
CMG icon
Chipotle Mexican Grill
CMG
+$421K

Top Sells

1
BIIB icon
Biogen
BIIB
+$2.42M
2
MDVN
MEDIVATION, INC.
MDVN
+$708K
3
CELG
Celgene Corp
CELG
+$557K
4
TWTR
Twitter, Inc.
TWTR
+$484K
5
WFM
Whole Foods Market Inc
WFM
+$307K

Sector Composition

1 Technology 23.7%
2 Consumer Discretionary 20.99%
3 Financials 12.4%
4 Healthcare 10.45%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOX icon
26
Box
BOX
$4.22B
$1.87M 1.8%
118,900
+700
+0.6% +$8.87K
PTLA
27
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.85M 1.78%
81,700
+6,550
+9% +$154K
LOGM
28
DELISTED
LogMein, Inc.
LOGM
$1.85M 1.78%
20,450
+50
+0.2% +$4K
MNDT
29
DELISTED
Mandiant, Inc. Common Stock
MNDT
$1.79M 1.72%
121,785
+19,750
+19% +$303K
ABBV icon
30
AbbVie
ABBV
$450B
$1.71M 1.64%
27,100
– –
ICPT
31
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.69M 1.62%
10,275
+25
+0.2% +$3.94K
AAPL icon
32
Apple
AAPL
$4.9T
$1.51M 1.45%
53,500
-600
-1% -$15.9K
EW icon
33
Edwards Lifesciences
EW
$49.4B
$1.5M 1.44%
37,200
-75
-0.2% -$2.83K
P
34
Everpure Inc
P
$23.1B
$1.49M 1.43%
109,825
+59,825
+120% +$747K
WDAY icon
35
Workday
WDAY
$35.8B
$1.46M 1.4%
15,950
-450
-3% -$37.5K
GRUB
36
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$1.3M 1.25%
15,075
+5,000
+50% +$375K
MMM icon
37
3M
MMM
$83.4B
$1.29M 1.24%
8,743
– –
GHL
38
DELISTED
Greenhill & Co., Inc.
GHL
$1.27M 1.22%
53,925
+550
+1% +$11.5K
XOM icon
39
ExxonMobil
XOM
$611B
$1.23M 1.18%
14,100
– –
CELG
40
DELISTED
Celgene Corp
CELG
$1.18M 1.13%
11,300
-5,150
-31% -$557K
PBPB
41
DELISTED
Potbelly
PBPB
$1.13M 1.08%
90,750
-2,000
-2% -$25.9K
WFM
42
DELISTED
Whole Foods Market Inc
WFM
$1M 0.96%
35,400
-9,975
-22% -$307K
SSYS icon
43
Stratasys
SSYS
$707M
$977K 0.94%
40,575
+150
+0.4% +$3.27K
GBT
44
DELISTED
Global Blood Therapeutics, Inc.
GBT
$694K 0.67%
30,100
– –
ACHN
45
DELISTED
Achillion Pharmaceuticals
ACHN
$608K 0.58%
+75,000
New +$638K
CLDX icon
46
Celldex Therapeutics
CLDX
$2.77B
$453K 0.44%
7,480
+40
+0.5% +$2.49K
DIS icon
47
Walt Disney
DIS
$170B
$390K 0.37%
4,205
– –
JPM icon
48
JPMorgan Chase
JPM
$907B
$383K 0.37%
5,750
– –
FUEL
49
DELISTED
Rocket Fuel Inc.
FUEL
$283K 0.27%
107,371
-3,700
-3% -$9.84K
ABT icon
50
Abbott
ABT
$175B
$270K 0.26%
6,375
+875
+16% +$37.5K
1
2
3

Similar funds

PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
RIA
Rocaton Investment Advisors Norwalk, Connecticut $36.6M AUM 10.31% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
IP
Ironsides Partners Boston, Massachusetts $27.7M AUM 1.11% 1-Year Est. Return
DCM
Dearborn Capital Management Chicago, Illinois $41.6M AUM 2.79% 1-Year Est. Return
PA
Pastel & Associes Paris, France $43.8M AUM 18.14% 1-Year Est. Return
P
PhaseCapital New York $45.2M AUM 8.85% 1-Year Est. Return
MCAI
Meritech Capital Associates III Palo Alto, California $45.8M AUM 24.9% 1-Year Est. Return

Marcus Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Marcus Capital held 52 positions worth $104M, up 9.6% from $95M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trading was light in Q3 2016: portfolio turnover was 3.8%. Marcus Capital opened 1 new position and exited 1, leaving the 52-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marcus Capital's largest Q3 2016 buy was Achillion Pharmaceuticals: 75,000 shares worth $608K.
  • Marcus Capital added most to Costco in Q3 2016, an estimated $824K increase.
  • Marcus Capital's biggest Q3 2016 reduction was MEDIVATION, INC., cutting an estimated $708K.
  • Marcus Capital fully exited Biogen in Q3 2016, selling an estimated $2.42M.
  • Marcus Capital's ten largest holdings make up 36% of its $104M portfolio in Q3 2016.
  • Marcus Capital opened 1 new position and closed 1 in Q3 2016.
  • Marcus Capital's portfolio value rose 9.6% quarter-over-quarter to $104M.

Based on Marcus Capital's 13F filing for Q3 2016, filed 8 Nov 2016.